Abstract
1 The effects of α- and β-adrenoceptor stimulants on the histamine-forming capacity (HFC) of human isolated leucocytes have been studied, in vitro.
2 It was confirmed that antigen significantly stimulates the HFC of human leucocytes.
3 β-Adrenoceptor stimulants, such as isoprenaline and salbutamol (10-6-10-3 M) significantly inhibited the HFC of human leucocytes in the presence and absence of antigen. At concentrations lower than 10-6 M, this effect was not observed. In general the degree of inhibition of HFC by β-adrenoceptor stimulants followed their potency as β-adrenoceptor stimulants.
4 α-Adrenoceptor stimulants significantly stimulated leucocyte HFC; noradrenaline within a limited concentration of 10-6 M, while stimulation was seen consistently with phenylephrine at concentrations of 10-7-10-4 M. Adrenaline, which stimulates both α- and β-adrenoceptors, produced small inhibition, no effect, or a degree of stimulation.
5 Phentolamine, an α-adrenoceptor blocking agent, produced an effect opposite to that of the α-adrenoceptor stimulants, i.e. a significant inhibition of the HFC of human isolated leucocytes.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alston W. C., Patel K. R., Kerr J. W. Response of leucocyte adenyl cyclase to isoprenaline and effect of alpha-blocking drugs in extrinsic bronchial asthma. Br Med J. 1974 Jan 19;1(5898):90–93. doi: 10.1136/bmj.1.5898.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Assem E. S., Feigenbaum J. J. Effect of adrenergic drugs on histamine forming capacity of human leucocytes. Br J Pharmacol. 1972 Nov;46(3):519P–520P. doi: 10.1111/j.1476-5381.1972.tb08152.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Assem E. S., Schild H. O. Antagonism by beta-adrenoceptor blocking agents of the antianaphylactic effect of isoprenaline. Br J Pharmacol. 1971 Aug;42(4):620–630. doi: 10.1111/j.1476-5381.1971.tb07146.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Assem E. S., Schild H. O. Inhibition by sympathomimetic amines of histamine release by antigen in passively sensitized human lung. Nature. 1969 Dec 6;224(5223):1028–1029. doi: 10.1038/2241028a0. [DOI] [PubMed] [Google Scholar]
- Assem E. S., Schild H. O. Inhibition of the anaphylactic mechanism by sympathomimetic amines. Int Arch Allergy Appl Immunol. 1971;40(4-5):576–589. doi: 10.1159/000230439. [DOI] [PubMed] [Google Scholar]
- Assem E. S., Schild H. O., Vickers M. R. Stimulation of histamine-forming capacity by antigen in sensitized human leucocytes. Int Arch Allergy Appl Immunol. 1972;42(3):343–352. doi: 10.1159/000230617. [DOI] [PubMed] [Google Scholar]
- Assem E. S., Turner-Warwick M., Cole P., Shaw K. M. Reversed anaphylactic reaction of leucocytes in intrinsic asthma. Clin Allergy. 1971 Dec;1(4):353–361. doi: 10.1111/j.1365-2222.1971.tb00786.x. [DOI] [PubMed] [Google Scholar]
- KAHLSON G., ROSENGREN E., THUNBERG R. OBSERVATIONS ON THE INHIBITION OF HISTAMINE FORMATION. J Physiol. 1963 Dec;169:467–486. doi: 10.1113/jphysiol.1963.sp007273. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kooman W. J., Orange R. P., Austen K. F. Immunochemical and biologic properties of rat IgE. 3. Modulation of the IgE-mediated release of slow-reacting substance of anaphylaxis by agents influencing the level of cyclic 3',5'-adenosine monoposphate. J Immunol. 1970 Nov;105(5):1096–1102. [PubMed] [Google Scholar]
- LICHTENSTEIN L. M., OSLER A. G. STUDIES ON THE MECHANISMS OF HYPERSENSITIVITY PHENOMENA. IX. HISTAMINE RELEASE FROM HUMAN LEUKOCYTES BY RAGWEED POLLEN ANTIGEN. J Exp Med. 1964 Oct 1;120:507–530. doi: 10.1084/jem.120.4.507. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lichtenstein L. M., Margolis S. Histamine release in vitro: inhibition by catecholamines and methylxanthines. Science. 1968 Aug 30;161(3844):902–903. doi: 10.1126/science.161.3844.902. [DOI] [PubMed] [Google Scholar]
- Robison G. A., Butcher R. W., Sutherland E. W. Adenyl cyclase as an adrenergic receptor. Ann N Y Acad Sci. 1967 Feb 10;139(3):703–723. doi: 10.1111/j.1749-6632.1967.tb41239.x. [DOI] [PubMed] [Google Scholar]